Yixintang Pharmaceutical Group Co., Ltd.
一心堂
002727
Shenzhen Stock Exchange
Company Profile
The company's core business is pharmaceutical retail chain and distribution, with the retail chain being its primary focus. It has now become one of the leading direct-operated retail chain enterprises in China. Currently, the company prioritizes development in the Southwest and South China regions while also expanding stores in North China. Its pharmaceutical retail operations cover Yunnan, Sichuan, Chongqing, Guangxi, Guizhou, Hainan, Shanxi, Henan, Shanghai, and Tianjin. Its wholly-owned subsidiary, Sichuan Bencaotang Pharmaceutical Co., Ltd., primarily engages in drug distribution and retail pharmacy franchising. The company has been honored as the fifth-ranked enterprise in the 2024–2025 China Pharmacy Value List by China Pharmacy, fifth in the 2023–2024 China Chain Pharmacy Comprehensive Strength Top 100 List by Minitube, second in the 2023–2024 China Chain Pharmacy Direct Operation Top 100 List by Minitube, and first in the 2022 China Chain Pharmacy Direct Store Quantity Ranking by Minitube.
Full description
R1: "Internet plus" must be translated as "Internet plus" The company's main business is pharmaceutical retail chain and distribution, with its core operations centered around the health industry chain. Focusing on pharmaceutical retail chain as the core and pharmaceutical wholesale as the support, it simultaneously extends into the full industrial chain of traditional Chinese medicine, medical and health services, and internet-based pharmaceuticals. It continuously deepens its engagement in the health industry, adhering to the development strategy of "direct operation as the primary model, franchising as supplementary, regional深耕, and national expansion." This has built a diversified business system encompassing "pharmaceutical retail + pharmaceutical wholesale + traditional Chinese medicine industry + medical and health services + internet-based pharmaceuticals," dedicated to providing consumers with comprehensive, specialized, and convenient health products and services. It persistently drives the transformation and upgrading from a pharmaceutical sales provider to a public health service provider, with all operations advancing steadily and synergistically.